Related Experiment Videos
Genetic heterogeneity in acute myeloid leukemia: maximizing information flow from MuLV mutagenesis studies
1Department of Genetics, Cell Biology and Development, Institute of Human Genetics, and University of Minnesota Cancer Center, University of Minnesota, Minneapolis 55455, USA.
Abstract:
The study of myeloid leukemia induced by slow transforming murine leukemia viruses (MuLV) in the laboratory mouse has led to discovery of many important genes with critical roles in regulating the growth, death, lineage determination and development of hematopoietic precursor cells. This review provides an overview of the susceptible strains and virus isolates that cause acute myeloid leukemia (AML) in mice. In addition, newer methodologies, involving the use of the polymerase chain reaction, that have been used to identify cancer genes mutated by proviral insertion in mouse models, will be discussed. As cancer is a multi-gene disease, a system in which pairs of oncogenic mutations are classified as redundant, neutral or synergistic is described. The potential to combine MuLV mutagenesis with recent advances in mouse transgenesis in order to model specific forms of myeloid leukemia or genetic pathways common in human AML will be discussed. Finally, a general strategy for maximizing these genetically rich models to foster a better understanding of AML physiology and developing therapies is proposed.
Insights
Murine leukemia viruses (MuLV) induce myeloid leukemia in mice, aiding the discovery of critical genes in hematopoietic cell development. This review explores mouse models for acute myeloid leukemia (AML) and therapeutic strategies.
Area of Science:
- Hematology
- Oncology
- Virology
Background:
- Murine leukemia viruses (MuLV) are instrumental in studying hematopoietic precursor cell regulation.
- Mouse models are crucial for understanding the genetic basis of acute myeloid leukemia (AML).
Purpose of the Study:
- To review susceptible mouse strains and MuLV isolates causing AML.
- To discuss methodologies for identifying cancer genes in MuLV-induced AML models.
- To explore combining MuLV mutagenesis with transgenesis for modeling human AML.
Main Methods:
- Utilizing polymerase chain reaction (PCR) to detect proviral insertion mutations.
- Classifying oncogenic mutation interactions (redundant, neutral, synergistic).
- Integrating MuLV mutagenesis with mouse transgenesis.
Main Results:
- Identification of key genes regulating hematopoietic cell growth, death, and lineage determination.
- Characterization of genetic pathways common in human AML through mouse models.
- Development of a system for classifying oncogenic mutation interactions.
Conclusions:
- MuLV-induced mouse models offer valuable insights into AML pathogenesis.
- Advanced methodologies enhance the identification of cancer-driving mutations.
- Combining mutagenesis and transgenesis can create specific AML models for therapeutic development.